Corneal eye disease is a fascinating sector of ophthalmology. Corneal opacity and scarring are one of the leading causes of vision loss and blindness worldwide. These conditions cause impairment of vision and poor quality of life. Until several decades ago, our ability to treat such diseases was limited. Dramatic improvements have occurred in all corneal diseases; on the surgical side, the lamellar corneal procedures have been revolutionary. Moreover, the development of a broad range of antimicrobial agents, anti-inflammatory drugs, systemic monoclonal antibodies, and vastly improved and faster diagnostic methods have revolutionized our ability in the diagnosis and management of these pathologies.
This Research Topic aims to provide a platform for original research, review, or case reports focusing on corneal diseases, both on surgical and on medical therapy. The advances reported here not only will help ophthalmologists and researchers but also assist in disseminating this knowledge to all clinicians.
We welcome submissions focusing on, but not limited to the following aspects:
• Epidemiological features and risk factors of corneal diseases causing visual loss.
• Recent advances in the diagnosis and management of the most common corneal diseases, especially related to general conditions of internal medicine.
• Recent advances on surgical therapies for corneal diseases.
• Recent advances in medical therapies for corneal diseases, such as anti-inflammatory drugs, antimicrobials, and monoclonal antibodies.
Corneal eye disease is a fascinating sector of ophthalmology. Corneal opacity and scarring are one of the leading causes of vision loss and blindness worldwide. These conditions cause impairment of vision and poor quality of life. Until several decades ago, our ability to treat such diseases was limited. Dramatic improvements have occurred in all corneal diseases; on the surgical side, the lamellar corneal procedures have been revolutionary. Moreover, the development of a broad range of antimicrobial agents, anti-inflammatory drugs, systemic monoclonal antibodies, and vastly improved and faster diagnostic methods have revolutionized our ability in the diagnosis and management of these pathologies.
This Research Topic aims to provide a platform for original research, review, or case reports focusing on corneal diseases, both on surgical and on medical therapy. The advances reported here not only will help ophthalmologists and researchers but also assist in disseminating this knowledge to all clinicians.
We welcome submissions focusing on, but not limited to the following aspects:
• Epidemiological features and risk factors of corneal diseases causing visual loss.
• Recent advances in the diagnosis and management of the most common corneal diseases, especially related to general conditions of internal medicine.
• Recent advances on surgical therapies for corneal diseases.
• Recent advances in medical therapies for corneal diseases, such as anti-inflammatory drugs, antimicrobials, and monoclonal antibodies.
